Peter B. Otoupal

This study evaluates subretinal delivery of Cas9 ribonucleoproteins in mice and pigs, showing variable editing efficiency and highlighting species-specific challenges for therapeutic translation.

This paper demonstrates the bioconversion of cellulose into bisabolene, a biojet fuel candidate, using rumen bacteria and non-conventional yeast in a sequential bioprocess.

This paper identifies gene expression perturbations that enhance antibiotic efficacy against MDR bacteria without fitness costs, demonstrating therapeutic potential in both E. coli and Salmonella.

This paper demonstrates the first use of CRISPR-Cas9 for targeted gene disruption in Rhodosporidium toruloides, achieving efficient multiplexed genome editing for bioproduct engineering.